Trial
NCT06878833
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Lyndra Inc.
Collaborators
—
Condition
Schizophrenia
Intervention
LYN-005 (risperidone)
Why stopped
Sponsor stopped operations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-08